Feline leukaemia virus: Half a century since its discovery

Veterinary Journal

Volumn 195, Issue 1, 2013, Pages 16-23

  Willett, Brian J ^a   Hosie, Margaret J ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Diagnosis; Feline leukaemia virus; Pathogenesis; Receptors; Transmission; Vaccination

Indexed keywords

CARRIER PROTEIN; CELL RECEPTOR; FELINE LEUKEMIA VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; STAVUDINE; THIAMINE TRANSPORTER 1; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; BLACKFAN DIAMOND ANEMIA; CELLULAR IMMUNITY; FELINE LEUKEMIA; FELINE LEUKEMIA VIRUS; FELINE LEUKEMIA VIRUS A; FELINE LEUKEMIA VIRUS B; FELINE LEUKEMIA VIRUS C; HUMORAL IMMUNITY; INFECTION PREVENTION; INFECTION SENSITIVITY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; VACCINATION; VETERINARY MEDICINE; VIRAL CLEARANCE; VIRAL TROPISM; VIREMIA; VIRION; VIRUS DETECTION; VIRUS GENOME; VIRUS INTERFERENCE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; VIRUS TYPING; ANIMAL; CAT; HISTORY; ISOLATION AND PURIFICATION; PHYSIOLOGY; VIROLOGY;

FELIDAE; MURINAE; MUS;

ANIMALS; CATS; HISTORY, 20TH CENTURY; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE;

EID: 84871401692     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.07.004     Document Type: Review

References (83)

1. Anderson M.M., Lauring A.S., Robertson S., Dirks C., Overbaugh J. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. Journal of Virology 2001, 75:10563-10572.
2. Benveniste R.E., Sherr C.J., Todaro G.J. Evolution of type C viral genes: Origin of feline leukemia virus. Science 1975, 190:886-888.
3. Benveniste R.E., Todaro G.J. Gene-transfer between eukaryotes. Science 1982, 217. 1202.
4. Brodey, R.S., McDonough, S.K., Frye, F.L., Hardy, W.D., 1970. Epidemiology of feline leukemia (lymphosarcoma). Bibliotheca Haematologica 333-342.
5. Brown M.A., Cunningham M.W., Roca A.L., Troyer J.L., Johnson W.E., O'Brien S.J. Genetic characterization of feline leukemia virus from Florida panthers. Emerging Infectious Diseases 2008, 2008:252-259.
6. Busch M.P., Devi B.G., Soe L.H., Perbal B., Baluda M.A., Roy-Burman P. Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells. Hematological Oncology 1983, 1:61-75.
7. Cunningham M.W., Brown M.A., Shindle D.B., Terrell S.P., Hayes K.A., Ferree B.C., McBride R.T., Blankenship E.L., Jansen D., Citino S.B., Roelke M.E., Kiltie R.A., Troyer J.L., O'Brien S.J. Epizootiology and management of feline leukemia virus in the Florida puma. Journal of Wildlife Diseases 2008, 2008:537-552.
8. de Beaumont G. Remarques sur la classification des Felidae. Eclogae Geologicae Helvetiae 1964, 57:837-845.
9. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., Ball S., Tchernia G., Klar J., Matsson H., Tentler D., Mohandas N., Carlsson B., Dahl N. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nature Genetics 1999, 21:169-175.
10. Duffy S.P., Shing J., Saraon P., Berger L.C., Eiden M.V., Wilde A., Tailor C.S. The Fowler syndrome-associated protein FLVCR2 is an importer of heme. Molecular and Cellular Biology 2010, 30:5318-5324.
11. Filoni C., Catão-Dias J.L., Cattori V., Willi B., Meli M.L., Corrêa S.H., Marques M.C., Adania C.H., Silva J.C., Marvulo M.F., Ferreira Neto J.S., Durigon E.L., de Carvalho V.M., Coutinho S.D., Lutz H., Hofmann-Lehmann R. Surveillance using serological and molecular methods for the detection of infectious agents in captive Brazilian neotropic and exotic felids. Journal of Veterinary Diagnostic Investigation 2012, 24:166-173.
12. Flynn J.N., Dunham S.P., Watson V., Jarrett O. Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: Correlation with recovery from infection. Journal of Virology 2002, 2002:2306-2315.
13. Flynn J.N., Hanlon L., Jarrett O. Feline leukaemia virus: Protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology 2000, 101:120-125.
14. Francis D.P., Essex M., Cotter S., Jakowski R.M., Hardy W.D. Feline leukemia virus infections, the significance of chronic viremia. Leukemia Research 1979, 3:435-441.
15. Francis D.P., Essex M., Gayzagian D. Feline leukemia virus: Survival under home and laboratory conditions. Journal of Clinical Microbiology 1979, 9:154-156.
16. Francis D.P., Essex M., Hardy W.D. Excretion of feline leukaemia virus by naturally infected pet cats. Nature 1977, 269:252-254.
17. Gomes-Keller M.A., Gonczi E., Grenacher B., Tandon R., Hofman-Lehmann R., Lutz H. Fecal shedding of infectious feline leukemia virus and its nucleic acids: A transmission potential. Veterinary Microbiology 2009, 134:208-217.
18. Gomes-Keller M.A., Tandon R., Gonczi E., Meli M.L., Hofmann-Lehmann R., Lutz H. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Veterinary Microbiology 2006, 112:11-21.
19. Hardy W.D., Hirshaut Y., Hess P. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibliotheca Haematologica 1973, 1973:778-799.
20. Helfer-Hungerbuehler A.K., Cattori V., Bachler B., Hartnack S., Riond B., Ossent P., Lutz H., Hofmann-Lehmann R. Quantification and molecular characterization of the feline leukemia virus A receptor. Infection, Genetics and Evolution 2001, 11:1940-1950.
21. Helfer-Hungerbuehler A.K., Cattori V., Boretti F.S., Ossent P., Grest P., Reinacher M., Henrich M., Bauer E., Bauer-Pham K., Niederer E., Holznagel E., Lutz H., Hofmann-Lehmann R. Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma. Retrovirology 2010, 7:14.
22. Hofmann-Lehmann R., Huder J.B., Gruber S., Boretti F., Sigrist B., Lutz H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. Journal of General Virology 2001, 82:1589-1596.
23. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., Lutz H. How molecular methods change our views of FeLV infection and vaccination. Veterinary Immunology and Immunopathology 2008, 123:119-123.
24. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., Pepin A.C., Willi B., Ossent P., Lutz H. Vaccination against the feline leukaemia virus: Outcome and response categories and long-term follow-up. Vaccine 2007, 25:5531-5539.
25. Hofmann-Lehmann R., Tandon R., Boretti F.S., Meli M.L., Willi B., Cattori V., Gomes-Keller M.A., Ossent P., Golder M.C., Flynn J.N., Lutz H. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 2006, 24:1087-1094.
26. Hoover E.A., Kociba G.J., Hardy W.D., Yohn D.S. Erythroid hypoplasia in cats inoculated with feline leukemia virus. Journal of the National Cancer Institute 1974, 53:1271-1276.
27. Hoover E.A., Olsen R.G., Hardy W.D., Schaller J.P., Mathes L.E. Feline leukemia virus infection: Age-related variation in response of cats to experimental infection. Journal of the National Cancer Institute 1976, 57:365-369.
28. Jarrett O., Hardy W.D., Golder M.C., Hay D. Frequency of occurrence of feline leukemia-virus subgroups in cats. International Journal of Cancer 1978, 21:334-337.
29. Jarrett O., Russell P.H. Differential growth and transmission in cats of feline leukemia viruses of subgroups A and B. International Journal of Cancer 1978, 21:466-472.
30. Jarrett W., Essex M., Mackey L., Jarrett O., Laird H. Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens. Journal of the National Cancer Institute 1973, 51:261-263.
31. Jarrett W., Jarrett O., Mackey L., Laird H., Hardy W., Essex M. Horizontal transmission of leukemia virus and leukemia in the cat. Journal of the National Cancer Institute 1973, 51:833-841.
32. Jarrett W., Jarrett O., Mackey L., Laird H., Hood C., Hay D. Vaccination against feline leukaemia virus using a cell membrane antigen system. International Journal of Cancer 1975, 16:134-141.
33. Jarrett W., Mackey L., Jarrett O., Laird H., Hood C. Antibody response and virus survival in cats vaccinated against feline leukaemia. Nature 1974, 248:230-232.
34. Jarrett, W.F.H., 1972. Feline leukemia. Journal of Clinical Pathology 6, 43-45.
35. Jarrett W.F.H., Mackey L.J. Neoplastic diseases of the haematopoietic and lymphoid tissues. Bulletin of the World Health Organization 1974, 50:21-34.
36. Jarrett W.F.H., Crawford E.M., Martin W.B., Davie F. A virus-like particle associated with leukemia (lymphosarcoma). Nature 1964, 202:567-569.
37. Johann S.V., Gibbons J.J., O'Hara B. GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. Journal of Virology 1992, 66:1635-1640.
38. Johnson W.E., Eizirik E., Pecon-Slattery J., Murphy W.J., Antunes A., Teeling E., O'Brien S.J. The late Miocene radiation of modern Felidae: A genetic assessment. Science 2006, 311:73-77.
39. Kawakami T.G., Theilen G.H., Dungworth D.L., Munn R.J., Beall S.G. 'C'-type viral particles in plasma of cats with feline leukemia. Science 1967, 158:1049-1050.
40. Labay V., Raz T., Baron D., Mandel H., Williams H., Barrett T., Szargel R., McDonald L., Shalata A., Nosaka K., Gregory S., Cohen N. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nature Genetics 1999, 22:300-304.
41. Lewis M.G., Mathes L.E., Olsen R.G. Protection against feline leukemia by vaccination with a subunit vaccine. Infection and Immunity 1981, 34:888-894.
42. Luaces I., Doménech A., García-Montijano M., Collado V.M., Sánchez C., Tejerizo J.G., Galka M., Fernández P., Gómez-Lucía E. Detection of feline leukemia virus in the endangered Iberian lynx (Lynx pardinus). Journal of Veterinary Diagnostic Investigation 2008, 20:381-385.
43. Lutz H., Addie D., Belák S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Marsilio F., Pennisi M.G., Radford A.D., Thiry E., Truyen U., Horzinek M.C. Feline leukaemia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:565-574.
44. Mackey L., Jarrett W., Jarrett O., Laird H. Anemia associated with feline leukemia virus infection in cats. Journal of the National Cancer Institute 1975, 54:209-217.
45. Madewell B.R., Jarrett O. Recovery of feline leukaemia virus from non-viraemic cats. Veterinary Record 1983, 112:339-342.
46. Marciani D.J., Kensil C.R., Beltz G.A., Hung C.H., Cronier J., Aubert A. Genetically-engineered subunit vaccine against feline leukaemia virus: Protective immune response in cats. Vaccine 1991, 1991:89-96.
47. McDougall A.S., Terry A., Tzavaras T., Cheney C., Rojko J., Neil J.C. Defective endogenous proviruses are expressed in feline lymphoid cells: Evidence for a role in natural resistance to subgroup B feline leukemia viruses. Journal of Virology 1994, 68:2151-2160.
48. Meli M.L., Cattori V., Martínez F., López G., Vargas A., Simón M.A., Zorrilla I., Muñoz A., Palomares F., López-Bao J.V., Pastor J., Tandon R., Willi B., Hofmann-Lehmann R., Lutz H. Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One 2009, 4:e4744.
49. Mendoza R., Anderson M.M., Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. Journal of Virology 2006, 80:3378-3385.
50. Meyer E., Ricketts C., Morgan N.V., Morris M.R., Pasha S., Tee L.J., Rahman F., Bazin A., Bessières B., Déchelotte P., Yacoubi M.T., Al-Adnani M., Marton T., Tannahill D., Trembath R.C., Fallet-Bianco C., Cox P., Williams D., Maher E.R. Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome). American Journal of Human Genetics 2010, 86:471-478.
51. O'Hara B., Johann S.V., Klinger H.P., Blair D.G., Rubinson H., Dunn K.J., Sass P., Vitek S.M., Robins T. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth and Differentiation 1990, 1:119-127.
52. Onions D.E., Jarrett O., Testa N.G., Frassoni F., Toth S. Selective effect of feline leukemia-virus on early erythroid precursors. Nature 1982, 296:156-158.
53. Osterhaus A., Weijer K., Uytdehaag F., Jarrett O., Sundquist B., Morein B. Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM. Journal of Immunology 1985, 135:591-596.
54. Overbaugh J., Riedel N., Hoover E.A., Mullins J.I. Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature 1988, 332:731-734.
55. Pacitti A.M., Jarrett O. Duration of the latent state in feline leukaemia virus infections. Veterinary Record 1985, 117:472-474.
56. Pedersen N.C., Theilen G.H., Werner L.L. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines. American Journal of Veterinary Research 1979, 40:1120-1126.
57. Poulet H., Brunet S., Boularand C., Guiot A.L., Leroy V., Tartaglia J., Minke J., Audonnet J.C., Desmettre P. Efficacy of a canarypox virus-vectored vaccine against feline leukaemia. Veterinary Record 2003, 153:141-145.
58. Quigley J.G., Burns C.C., Anderson M.M., Lynch E.D., Sabo K.M., Overbaugh J., Abkowitz J.L. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 2000, 95:1093-1099.
59. Quigley J.G., Yang Z., Worthington M.T., Phillips J.D., Sabo K.M., Sabath D.E., Berg C.L., Sassa S., Wood B.L., Abkowitz J.L. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004, 118:757-766.
60. Rey M.A., Duffy S.P., Brown J.K., Kennedy J.A., Dick J.E., Dror Y., Tailor C.S. Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis. Haematologica 2008, 93:1617-1626.
61. Rickard C.G., Post J.E., Noronha F., Barr L.M. A transmissible virus-induced lymphocytic leukemia of the cat. Journal of the National Cancer Institute 1969, 42:987-1014.
62. Riedel N., Hoover E.A., Gasper P.W., Nicolson M.O., Mullins J.I. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. Virology 1986, 60:242-250.
63. Rigby M.A., Rojko J.L., Stewart M.A., Kociba G.J., Cheney C.M., Rezanka L.J., Mathes L.E., Hartke J.R., Jarrett O., Neil J.C. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia virus with chimeric envelope genes. Journal of General Virology 1992, 73:2839-2847.
64. Roca A.L., Nash W.G., Menninger J.C., Murphy W.J., O'Brien S.J. Insertional polymorphisms of endogenous feline leukemia viruses. Journal of Virology 2005, 79:3979-3986.
65. Roca A.L., Pecon-Slattery J., O'Brien S.J. Genomically intact endogenous feline leukemia viruses of recent origin. Journal of Virology 2004, 78:4370-4375.
66. Rojko J.L., Hoover E.A., Mathes L.E., Krakowka S., Olsen R.G. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Cancer Research 1979, 39:3789-3791.
67. Rojko J.L., Hoover E.A., Quackenbush S.L., Olsen R.G. Reactivation of latent feline leukaemia virus infection. Nature 1982, 298:385-388.
68. Roy-Burman P. Endogenous env elements: Partners in generation of pathogenic feline leukemia viruses. Virus Genes 1995, 11:147-161.
69. Sarma P.S., Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 1973, 54:160-169.
70. Sarma P.S., Log T. Viral interference in feline leukemia-sarcoma complex. Virology 1971, 44:352-358.
71. Schaller J.P., Mathes L.E., Hoover E.A., Koestner A., Olsen R.G. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea. Cancer Research 1978, 38:996-998.
72. Shalev Z., Duffy S.P., Adema K.W., Prasad R., Hussain N., Willett B.J., Tailor C.S. Journal of Virology 2009, 2009:6706-6716.
73. Sheets R.L., Pandey R., Klement V., Grant C.K., Roy-Burman P. Biologically selected recombinants between feline leukemia virus (FeLV) subgroup A and an endogenous FeLV element. Virology 1992, 190:849-855.
74. Stewart H., Adema K.W., McMonagle E.L., Hosie M.J., Willett B.J. Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus. Retrovirology 2012, 9:48.
75. Stewart H., Jarrett O., Hosie M.J., Willett B.J. Are endogenous feline leukemia viruses really endogenous?. Veterinary Immunology and Immunopathology 2011, 143:325-331.
76. Stewart M.A., Warnock M., Wheeler A., Wilkie N., Mullins J.I., Onions D.E., Neil J.C. Nucleotide sequences of a feline leukaemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinatorial origin of subgroup B viruses. Journal of Virology 1986, 58:825-834.
77. Tailor C.S., Willett B.J., Kabat D. The cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. Journal of Virology 1999, 73:6500-6505.
78. Takeuchi Y., Vile R.G., Simpson G., O'Hara B., Collins M.K.L., Weiss R.A. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. Journal of Virology 1992, 66:1219-1222.
79. Tandon R., Cattori V., Willi B., Meli M.L., Gomes-Keller M.A., Lutz H., Hofmann-Lehmann R. Copy number polymorphism of endogenous feline leukemia virus-like sequences. Molecular and Cellular Probes 2007, 21:257-266.
80. Tartaglia J., Jarrett O., Neil J.C., Desmettre P., Paoletti E. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. Journal of Virology 1993, 67:2370-2375.
81. Theilen G.H., Kawakami T.G., Rush J.D., Munn R.J. Replication of cat leukemia virus in cell suspension cultures. Nature 1969, 222:589-590.
82. Torres A.N., Mathiason C.K., Hoover E.A. Re-examination of feline leukemia virus: Host relationships using real-time PCR. Virology 2005, 332:272-283.
83. Willig T.N., Draptchinskaia N., Dianzani I., Ball S., Niemeyer C., Ramenghi U., Orfali K., Gustavsson P., Garelli E., Brusco A., Tiemann C., Pérignon J.L., Bouchier C., Cicchiello L., Dahl N., Mohandas N., Tchernia G. Mutations in ribosomal protein S19 gene and Diamond Blackfan anemia: Wide variations in phenotypic expression. Blood 1999, 1999:4294-4306.